Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Johnson & Johnson

< Previous 1 2 3 Next >
Johnson & Johnson Completes Acquisition of Ambrx
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q4 and Full-Year 2023 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Acquire Ambrx, Advancing Next Generation Antibody Drug Conjugates to Transform the Treatment of Cancer
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Enterprise Business Review
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2023
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Reports Q3 2023 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Marks New Era as Global Healthcare Company With Updated Visual Identity
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Updated Financials and 2023 Guidance Following Completion of the Kenvue Separation
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Final Results of Exchange Offer and Finalizes Separation of Kenvue Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson Announces Final Exchange Ratio of 8.0324 in Split-Off of Kenvue Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ KVUE
Johnson & Johnson to Participate in the 2023 Wells Fargo Securities Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc.
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2023
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Reports Q2 2023 Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
From Johnson & Johnson
Via Business Wire
Tickers JNJ
Johnson & Johnson and Kenvue Announce Pricing of Upsized Kenvue Inc. Initial Public Offering
From Johnson & Johnson
Via Business Wire
Tickers JNJ
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.